End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
155,930 CLP | 0.00% |
|
0.00% | +14.33% |
06-20 | Johnson & Johnson Files Application With US FDA Seeking Approval of Tremfya to Treat Crohn's Disease | MT |
06-20 | J&J: launches open, secure digital ecosystem | CF |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJCL Stock
- News Johnson & Johnson
- Official Publications